Purpura [clinicaltrials_resource:054b9b0e8b7aed8d0ae870ea3cb8366a]
Topical Vitamin A Versus Vehicle Cream in the Treatment of Aged Skin [clinicaltrials:NCT00272610]clinicaltrials:NCT01506414clinicaltrials:NCT01525836Recombinant Human Thrombopoietin (rhTPO) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) [clinicaltrials:NCT01734044]Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) [clinicaltrials:NCT01734057]All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP) [clinicaltrials:NCT01882127]clinicaltrials:NCT01910831
condition [clinicaltrials_vocabulary:condition]
A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura [clinicaltrials:NCT00002250]An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers [clinicaltrials:NCT00005570]Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura [clinicaltrials:NCT00005652]Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases [clinicaltrials:NCT00006055]AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy [clinicaltrials:NCT00102323]AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy [clinicaltrials:NCT00102336]SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00102739]Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura [clinicaltrials:NCT00107913]Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP) [clinicaltrials:NCT00111475]clinicaltrials:NCT00116688Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00117143]Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D [clinicaltrials:NCT00128882]Efficacy and Safety of IVIG-L in ITP Patients [clinicaltrials:NCT00151840]Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura [clinicaltrials:NCT00162006]clinicaltrials:NCT00168038Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura [clinicaltrials:NCT00190229]clinicaltrials:NCT00220727Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy [clinicaltrials:NCT00225875]Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00244257]Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura [clinicaltrials:NCT00251277]Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN [clinicaltrials:NCT00301613]Safety Study of AMG 531 in Japanese Subjects With ITP [clinicaltrials:NCT00305435]Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire [clinicaltrials:NCT00331357]EXTEND (Eltrombopag Extended Dosing Study) [clinicaltrials:NCT00351468]Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients [clinicaltrials:NCT00362349]clinicaltrials:NCT00370331clinicaltrials:NCT00372892Safety and Efficacy Study To Compare Uniplas With Cryosupernatant Plasma In Thrombotic Thrombocytopenic Purpura (TTP) [clinicaltrials:NCT00411801]clinicaltrials:NCT00415532clinicaltrials:NCT00424177clinicaltrials:NCT00426270ADAMTS13 in Thrombotic Thrombocytopenic Purpura [clinicaltrials:NCT00426686]Open Label Extension Study of AMG 531 in Japanese Subjects With ITP [clinicaltrials:NCT00440037]Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00441090]High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP [clinicaltrials:NCT00451594]clinicaltrials:NCT00454857Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura [clinicaltrials:NCT00467571]clinicaltrials:NCT00475423clinicaltrials:NCT00504075clinicaltrials:NCT00508820
condition browse [clinicaltrials_vocabulary:condition-browse]
A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura [clinicaltrials:NCT00002250]An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers [clinicaltrials:NCT00005570]Phase II Study of Rituximab in Patients With Immune Thrombocytopenic Purpura [clinicaltrials:NCT00005652]Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases [clinicaltrials:NCT00006055]AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy [clinicaltrials:NCT00102323]AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy [clinicaltrials:NCT00102336]SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00102739]Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura [clinicaltrials:NCT00107913]Evaluating the Safety and Efficacy of AMG531 in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura(ITP) [clinicaltrials:NCT00111475]clinicaltrials:NCT00116688Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00117143]Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D [clinicaltrials:NCT00128882]Efficacy and Safety of IVIG-L in ITP Patients [clinicaltrials:NCT00151840]Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura [clinicaltrials:NCT00162006]clinicaltrials:NCT00168038Efficacy of Steroid Versus Steroid Plus Cyclophosphamide for Severe Henoch-Schoenlein Purpura [clinicaltrials:NCT00190229]clinicaltrials:NCT00220727Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy [clinicaltrials:NCT00225875]Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00244257]Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura [clinicaltrials:NCT00251277]Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN [clinicaltrials:NCT00301613]Safety Study of AMG 531 in Japanese Subjects With ITP [clinicaltrials:NCT00305435]Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire [clinicaltrials:NCT00331357]EXTEND (Eltrombopag Extended Dosing Study) [clinicaltrials:NCT00351468]Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients [clinicaltrials:NCT00362349]clinicaltrials:NCT00370331clinicaltrials:NCT00372892Safety and Efficacy Study To Compare Uniplas With Cryosupernatant Plasma In Thrombotic Thrombocytopenic Purpura (TTP) [clinicaltrials:NCT00411801]clinicaltrials:NCT00415532clinicaltrials:NCT00424177clinicaltrials:NCT00426270ADAMTS13 in Thrombotic Thrombocytopenic Purpura [clinicaltrials:NCT00426686]Open Label Extension Study of AMG 531 in Japanese Subjects With ITP [clinicaltrials:NCT00440037]Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) [clinicaltrials:NCT00441090]High Dose Dexamethasone Vs. Conventional Dose Prednisolone in Adult ITP [clinicaltrials:NCT00451594]clinicaltrials:NCT00454857Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura [clinicaltrials:NCT00467571]clinicaltrials:NCT00475423clinicaltrials:NCT00504075clinicaltrials:NCT00508820
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Purpura [clinicaltrials_resource:054b9b0e8b7aed8d0ae870ea3cb8366a]
Bio2RDF identifier
054b9b0e8b7aed8d0ae870ea3cb8366a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:054b9b0e8b7aed8d0ae870ea3cb8366a
identifier
clinicaltrials_resource:054b9b0e8b7aed8d0ae870ea3cb8366a
title
Purpura
@en
type
label
Purpura [clinicaltrials_resource:054b9b0e8b7aed8d0ae870ea3cb8366a]
@en